---
pmid: '34591612'
title: A protein interaction landscape of breast cancer.
authors:
- Kim M
- Park J
- Bouhaddou M
- Kim K
- Rojc A
- Modak M
- Soucheray M
- McGregor MJ
- O'Leary P
- Wolf D
- Stevenson E
- Foo TK
- Mitchell D
- Herrington KA
- Muñoz DP
- Tutuncuoglu B
- Chen KH
- Zheng F
- Kreisberg JF
- Diolaiti ME
- Gordan JD
- Coppé JP
- Swaney DL
- Xia B
- van 't Veer L
- Ashworth A
- Ideker T
- Krogan NJ
journal: Science
year: '2021'
pmcid: PMC9040556
doi: 10.1126/science.abf3066
---

# A protein interaction landscape of breast cancer.
**Authors:** Kim M, Park J, Bouhaddou M, Kim K, Rojc A, Modak M, Soucheray M, McGregor MJ, O'Leary P, Wolf D, Stevenson E, Foo TK, Mitchell D, Herrington KA, Muñoz DP, Tutuncuoglu B, Chen KH, Zheng F, Kreisberg JF, Diolaiti ME, Gordan JD, Coppé JP, Swaney DL, Xia B, van 't Veer L, Ashworth A, Ideker T, Krogan NJ
**Journal:** Science (2021)
**DOI:** [10.1126/science.abf3066](https://doi.org/10.1126/science.abf3066)
**PMC:** [PMC9040556](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040556/)

## Abstract

1. Science. 2021 Oct;374(6563):eabf3066. doi: 10.1126/science.abf3066. Epub 2021 
Oct 1.

A protein interaction landscape of breast cancer.

Kim M(1)(2)(3)(4), Park J(4)(5), Bouhaddou M(1)(2)(3)(4), Kim K(1)(2)(3)(4), 
Rojc A(1)(2)(3)(4), Modak M(1)(2)(3)(4), Soucheray M(1)(2)(3)(4), McGregor 
MJ(1)(2)(3)(4), O'Leary P(4)(6), Wolf D(4)(6), Stevenson E(1)(2)(3)(4), Foo 
TK(7), Mitchell D(3)(6)(8), Herrington KA(9), Muñoz DP(4)(6), Tutuncuoglu 
B(1)(2)(3)(4), Chen KH(1)(2)(3)(4), Zheng F(4)(5), Kreisberg JF(4)(5), Diolaiti 
ME(4)(6), Gordan JD(3)(6)(8), Coppé JP(4)(6), Swaney DL(1)(2)(3)(4), Xia B(7), 
van 't Veer L(4)(6), Ashworth A(4)(6), Ideker T(4)(5)(10), Krogan 
NJ(1)(2)(3)(4).

Author information:
(1)Department of Cellular and Molecular Pharmacology, University of California, 
San Francisco, CA, USA.
(2)The J. David Gladstone Institute of Data Science and Biotechnology, San 
Francisco, CA, USA.
(3)Quantitative Biosciences Institute, University of California, San Francisco, 
CA, USA.
(4)The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.
(5)Department of Medicine, University of California, San Diego, CA, USA.
(6)Department of Medicine, Helen Diller Family Comprehensive Cancer Center, 
University of California, San Francisco, CA, USA.
(7)Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New 
Brunswick, NJ, USA.
(8)Division of Hematology/Oncology, University of California, San Francisco, CA, 
USA.
(9)Department of Biochemistry and Biophysics, Center for Advanced Light 
Microscopy, University of California, San Francisco, CA, USA.
(10)Department of Bioengineering, University of California, San Diego, CA, USA.

Comment in
    Science. 2021 Oct;374(6563):38-39. doi: 10.1126/science.abl9080.

Cancers have been associated with a diverse array of genomic alterations. To 
help mechanistically understand such alterations in breast-invasive carcinoma, 
we applied affinity purification–mass spectrometry to delineate comprehensive 
biophysical interaction networks for 40 frequently altered breast cancer (BC) 
proteins, with and without relevant mutations, across three human breast cell 
lines. These networks identify cancer-specific protein-protein interactions 
(PPIs), interconnected and enriched for common and rare cancer mutations, that 
are substantially rewired by the introduction of key BC mutations. Our analysis 
identified BPIFA1 and SCGB2A1 as PIK3CA-interacting proteins, which repress 
PI3K-AKT signaling, and uncovered USP28 and UBE2N as functionally relevant 
interactors of BRCA1. We also show that the protein phosphatase 1 regulatory 
subunit spinophilin interacts with and regulates dephosphorylation of BRCA1 to 
promote DNA double-strand break repair. Thus, PPI landscapes provide a powerful 
framework for mechanistically interpreting disease genomic data and can identify 
valuable therapeutic targets.

DOI: 10.1126/science.abf3066
PMCID: PMC9040556
PMID: 34591612 [Indexed for MEDLINE]
